Peter Nanasi

Prof. Peter Nanasi

Department of Physiology, University of Debrecen, Debrecen, Hungary

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2014 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
NSNorbert Szentandrássy
Norbert Szentandrássy
KKKornel Kistamas
Kornel Kistamas
BHBence Hegyi
Bence Hegyi
BHBalázs Horváth
Balázs Horváth
FRFerenc Ruzsnavszky
Ferenc Ruzsnavszky
PNPeter Nanasi
Peter Nanasi

28 December 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CDCsaba Bálint Dienes
Csaba Bálint Dienes
ZKZsigmond Kovács
Zsigmond Kovács
THTamás Hézső
Tamás Hézső
JAJános Almássy
János Almássy
JMJanos Magyar
Janos Magyar
NSNorbert Szentandrássy
Norbert Szentandrássy
Transient receptor potential melastatin 4 (TRPM4) is a unique member of the TRPM protein family and, similarly to TRPM5, is Ca2+ sensitive and permeable for monovalent but not divalent cations. It is widely expressed in many organs and is involved in several functions; it regulates membrane potential and Ca2+ homeostasis in both excitable and non-excitable cells. This part of the review discusses the currently available knowledge about the physiological and pathophysiological roles of TRPM4 in various tissues. These include the physiological functions of TRPM4 in the cells of the Langerhans islets of the pancreas, in various immune functions, in the regulation of vascular tone, in respiratory and other neuronal activities, in chemosensation, and in renal and cardiac physiology. TRPM4 contributes to pathological conditions such as overactive bladder, endothelial dysfunction, various types of malignant diseases and central nervous system conditions including stroke and injuries as well as in cardiac conditions such as arrhythmias, hypertrophy, and ischemia-reperfusion injuries. TRPM4 claims more and more attention and is likely to be the topic of research in the future.

22 September 2017 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
BHBalázs Horváth
Balázs Horváth
NSNorbert Szentandrássy
Norbert Szentandrássy
RVRoland Veress
Roland Veress
JAJános Almássy
János Almássy
JMJános Magyar
János Magyar
PNPeter Nanasi
Peter Nanasi

1 February 2020 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
BHBalázs Horváth
Balázs Horváth
THTamás Hézső
Tamás Hézső
NSNorbert Szentandrássy
Norbert Szentandrássy
KKKornel Kistamas
Kornel Kistamas
TÁTamás Árpádffy-Lovas
Tamás Árpádffy-Lovas
PNPeter Nanasi
Peter Nanasi

Verified
Journal Article
Open access
PDF file
NSNorbert Szentandrássy
Norbert Szentandrássy
ZMZsuzsanna É. Magyar
Zsuzsanna É. Magyar
JHJudit Hevesi
Judit Hevesi
TBTamas Banyasz
Tamas Banyasz
PNPeter Nanasi
Peter Nanasi
JAJános Almássy
János Almássy
Cardiac diseases are the leading causes of death, with a growing number of cases worldwide, posing a challenge for both healthcare and research. Therefore, the most relevant aim of cardiac research is to unravel the molecular pathomechanisms and identify new therapeutic targets. Cardiac ryanodine receptor (RyR2), the Ca2+ release channel of the sarcoplasmic reticulum, is believed to be a good therapeutic target in a group of certain heart diseases, collectively called cardiac ryanopathies. Ryanopathies are associated with the impaired function of the RyR, leading to heart diseases such as congestive heart failure (CHF), catecholaminergic polymorphic ventricular tachycardia (CPVT), arrhythmogenic right ventricular dysplasia type 2 (ARVD2), and calcium release deficiency syndrome (CRDS). The aim of the current review is to provide a short insight into the pathological mechanisms of ryanopathies and discuss the pharmacological approaches targeting RyR2.

29 July 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PNPeter Nanasi
Peter Nanasi
BHBalazs Horvath
Balazs Horvath
FTFábián Tar
Fábián Tar
JAJános Almássy
János Almássy
NSNorbert Szentandrássy
Norbert Szentandrássy
AVAndras Varro
Andras Varro
Due to the limited availability of healthy human ventricular tissues, the most suitable animal model has to be applied for electrophysiological and pharmacological studies. This can be best identified by studying the properties of ion currents shaping the action potential in the frequently used laboratory animals, such as dogs, rabbits, guinea pigs, or rats, and comparing them to those of human cardiomyocytes. The authors of this article with the experience of three decades of electrophysiological studies, performed in mammalian and human ventricular tissues and isolated cardiomyocytes, summarize their results obtained regarding the major canine and human cardiac ion currents. Accordingly, L-type Ca2+ current (ICa), late Na+ current (INa-late), rapid and slow components of the delayed rectifier K+ current (IKr and IKs, respectively), inward rectifier K+ current (IK1), transient outward K+ current (Ito1), and Na+/Ca2+ exchange current (INCX) were characterized and compared. Importantly, many of these measurements were performed using the action potential voltage clamp technique allowing for visualization of the actual current profiles flowing during the ventricular action potential. Densities and shapes of these ion currents, as well as the action potential configuration, were similar in human and canine ventricular cells, except for the density of IK1 and the recovery kinetics of Ito. IK1 displayed a largely four-fold larger density in canine than human myocytes, and Ito recovery from inactivation displayed a somewhat different time course in the two species. On the basis of these results, it is concluded that canine ventricular cells represent a reasonably good model for human myocytes for electrophysiological studies, however, it must be borne in mind that due to their stronger IK1, the repolarization reserve is more pronounced in canine cells, and moderate differences in the frequency-dependent repolarization patterns can also be anticipated.